A.I.O.

This Week In Medicine

Health EN ↓ 212 episodes

Welcome to This Week in Medicine - Your Filtered Medical Journal SummaryLooking to stay up-to-date with the latest medical research but short on time? This Week in Medicine has you covered! Our AI generated podcast provides you with a convenient, on-the-go solution to keep you informed about the most significant developments in the medicine field. We understand that your time is valuable, so we've done the hard work for you. Each episode offers a filtered and concentrated summary of key journal articles, allowing you to stay informed without the need to sift through pages of research papers. W...

Author

A.I.O.

Category

Health

Podcast website

redcircle.com

Latest episode

Jul 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

NEJM January 2026 ORIGINAL ARTICLE Share on Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD 15.01.2026

This research study evaluates a groundbreaking subretinal photovoltaic implant designed to combat vision loss caused by geographic atrophy, a severe form of macular degeneration. By utilizing specialized glasses that beam near-infrared light onto a chip behind the retina, the system successfully restored central sight in a high majority of clinical trial participants. Over the course of a year, mo...

NEJM January 2026;Medical Management and Revascularization for Asymptomatic Carotid Stenosis 15.01.2026

This research study evaluates the most effective way to treat patients with severely blocked carotid arteries who have not yet experienced symptoms like a stroke. Researchers compared the results of intensive medical management alone against combining that medication with surgical interventions like stenting or endarterectomy. The findings revealed that while surgical stenting significantly lowere...

Lancet : January 2026 Mortality and long-term exposure to source-specific PM2·5: evidence from a national cohort study in China 11.01.2026

This research investigates how long-term exposure to fine particulate matter from different origins impacts death rates across mainland China. By tracking a diverse group of nearly 97,000 adults over a decade, the study demonstrates that air pollution is not a monolith, as toxins from industrial, residential, and transportation sectors show the strongest links to non-accidental and cardiopulmonary...

Lancet : January 2026:SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studies 11.01.2026

This research examined how oral antiviral medications influence the duration of contagiousness and the frequency of viral rebound in patients with COVID-19. By monitoring nasal swabs from high-risk adults, the study found that while treatment initially leads to an earlier cessation of infectious shedding, it also significantly increases the likelihood of a temporary resurgence of the virus. Ultima...

Lancet : January 2026, REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial 11.01.2026

This clinical study investigates a pioneering medical treatment called REGENECYTE, which utilizes umbilical cord blood cells to combat the persistent exhaustion associated with long COVID. By administering multiple intravenous infusions to a small group of patients, researchers discovered that this allogeneic progenitor cell therapy was not only safe but also led to a significant and lasting reduc...

NEJM January 8, 2026 RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults 09.01.2026

This research study evaluates the impact of a specific bivalent vaccine on reducing severe illness from respiratory syncytial virus (RSV) among individuals aged 60 and older. By comparing a large group of vaccinated seniors against an unvaccinated control group during a winter season, researchers discovered that the immunization offered significant protection against serious complications. The dat...

NEJM January 8, 2026 Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis 09.01.2026

This research study evaluates whether daily fish-oil supplements can protect the heart health of patients undergoing long-term hemodialysis, a group that faces a disproportionately high risk of mortality from circulatory issues. By comparing a high dose of omega-3 fatty acids against a placebo over several years, the investigators discovered that those receiving the active treatment experienced si...

NEJM January 8, 2026 09.01.2026

A recent clinical study investigated the effectiveness of evolocumab, a PCSK9 inhibitor, in preventing major cardiovascular events for individuals who have never suffered a heart attack or stroke. Researchers conducted a massive trial involving over 12,000 participants with underlying conditions like diabetes or atherosclerosis to see if the medication could lower their initial risk. The results d...

Circulation:January 6, 2026:Circulation:January 6, 2026 Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation 05.01.2026

This research introduces 3DRECON-QT, a sophisticated artificial intelligence system designed to enhance the safety of patients taking specific heart medications by monitoring their cardiac rhythm through a single-lead device. By using deep learning to reconstruct comprehensive spatial data from a limited signal, the model can accurately identify dangerous QT prolongation, a condition that signific...

Circulation:January 6, 2026 Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial 05.01.2026

The STORM-PE clinical trial investigated whether using a computer-assisted vacuum thrombectomy device to physically remove blood clots provides better outcomes for high-risk pulmonary embolism patients than standard medication alone. By comparing these two treatments, researchers discovered that the mechanical procedure was significantly more effective at reducing heart strain and normalizing vita...

Circulation:January 6, 2026 Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial 05.01.2026

The CAVIAR trial investigated whether adding the drug alirocumab to standard statin therapy could prevent artery disease in heart transplant recipients, a common cause of post-transplant mortality. While the study confirmed that this combination drastically lowered "bad" cholesterol levels without causing safety concerns, it failed to show a significant clinical benefit regarding physical...

THE LANCET: December 31, 2025:International trends and social disparities in pain of adults aged 50 years and older in 22 countries across Europe, Asia, and the Americas: a longitudinal population-based study 04.01.2026

This longitudinal study examines how chronic physical suffering evolved over two decades among aging populations across twenty-two different nations. By analyzing data from hundreds of thousands of individuals, researchers discovered that pain prevalence is rising globally, though the severity of this trend varies significantly depending on a country's specific geography and policies. The find...

THE LANCET Volume 407, Issue 10523P31-52January 03, 2026 Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden 04.01.2026

This comprehensive analysis examines the staggering global impact of domestic and childhood abuse on public health, revealing that over a billion people have endured such trauma. By quantifying the long-term health consequences across 204 countries, the researchers demonstrate that these violations are primary drivers of disability and disease, particularly through severe mental health disorders l...

N Engl J Med 2026;394:51-61 Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab 02.01.2026

patients suffering from a particularly aggressive form of cancer known as true extramedullary myeloma. By simultaneously attacking two different markers on cancer cells using the drugs talquetamab and teclistamab, researchers achieved a high overall response rate in a population that usually faces very poor odds. While the treatment proved effective at shrinking tumors and extending survival, it a...

NEJM: Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC 02.01.2026

This clinical study investigates whether combining the targeted drug osimertinib with traditional chemotherapy offers a superior outcome for patients facing a specific type of advanced lung cancer. By comparing this dual approach against the standard single-drug therapy, researchers discovered that the combination treatment significantly extended the livesof participants by nearly ten months. Whil...

N Engl J Med 2026;394:13-26 Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC 02.01.2026

This study evaluates the effectiveness of sacituzumab tirumotecan, a novel antibody-drug conjugate, for patients with advanced lung cancer whose disease has worsened despite standard treatments. By comparing this new drug against traditional chemotherapy, researchers discovered that it doubled the duration of progression-free survival and significantly extended the lives of those involved in the t...

Most Popular Articles JAMA 2025 Episode 2:Screening for Osteoporosis to Prevent Fractures US Preventive Services Task Force Recommendation Statement 31.12.2025

This clinical guideline establishes a framework for using medical screenings to identify bone density loss before it leads to debilitating injuries. The document highlights that osteoporotic fractures are severe events that can strip individuals of their independence or even lead to mortality. Based on a rigorous evidence assessment, the task force issues a formal recommendation for all women aged...

Most Popular Articles JAMA 2025 Episode 1:The DECAF Trial 31.12.2025

The DECAF Trial challenged the long-held medical assumption that caffeine triggers irregular heart rhythms by investigating its actual impact on patients with atrial fibrillation. Researchers conducted a randomized experiment where one group continued drinking caffeinated coffee while the other practiced complete abstinence following a heart procedure. Surprisingly, the data revealed that those wh...

The Lancet December 2025:Neurobehavioural links from infant screen time to anxiety 31.12.2025

This research explores how early exposure to digital media impacts the long-term mental health of children by tracing a specific neurodevelopmental pathway from infancy to adolescence. By monitoring brain growth over several years, scientists discovered that excessive screen time during the first two years of life leads to an accelerated maturation of brain networks responsible for vision and cogn...

Best of JAMA 2025: Episode 9:Nicotinamide for Skin Cancer Chemoprevention 27.12.2025

This extensive medical study investigates whether taking nicotinamide, a form of vitamin B3, can effectively serve as a preventative measure against skin cancer for both the general public and high-risk transplant patients. By analyzing health records from over 30,000 veterans, researchers discovered that a daily supplement significantly lowered the overall risk of developing further malignancies,...

Best of JAMA 2025: Episode 8:Association of Endothelial Dysfunction With Chronic Marijuana Smoking and THC-Edible Use 27.12.2025

The CANDIDE study investigated the impact of long-term cannabis use on cardiovascular health by comparing non-users to those who frequently smoke marijuana or consume THC-infused edibles. By measuring how well blood vessels dilate and testing cell reactions to user serum, researchers discovered that both forms of consumption lead to significant endothelial dysfunction, a condition where the lining...

Best of JAMA 2025: Episode 7: Global Estimates of Lives and Life-Years Saved by COVID-19 Vaccination During 2020-2024 27.12.2025

This research provides a comprehensive assessment of the global public health impact of COVID-19 immunizations from 2020 through late 2024. By analyzing diverse demographics and viral waves, the study concludes that vaccines prevented millions of deaths and preserved nearly 15 million life-years, though these benefits were not distributed equally across all age groups. The data reveals that the va...

Best of JAMA 2025: Episode 6:Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration 25.12.2025

This research study investigates a potential link between popular metabolic medications and a serious vision-threatening condition known as neovascular age-related macular degeneration. By analyzing a massive database of elderly patients with diabetes, scientists discovered that those who used GLP-1 receptor agonists for at least six months faced double the risk of developing this specific eye dis...

Best of JAMA 2025: Episode 5:Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors A Systematic Review and Individual Participant Data Meta-Analysis 23.12.2025

This comprehensive meta-analysis investigates the delicate balance between treating aggressive cancers and preserving donor organs in solid organ transplant recipients. Researchers discovered that while immune checkpoint inhibitors offer a vital lifeline, they carry a substantial risk of acute rejection and graft loss because the stimulated immune system may attack the transplanted organ. The stud...

Best of JAMA 2025: Episode 4:Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients With Atrial Fibrillation A Systematic Review and Meta-Analysis 23.12.2025

This meta-analysis investigates the residual risk of recurrent stroke in patients with atrial fibrillation who are already receiving modern medical treatment. Despite the widespread use of blood thinners, the study reveals that patients remain at a significant disadvantage, with roughly one in six individuals suffering another ischemic event within five years. The data highlights a particularly hi...

Listen to the This Week In Medicine podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.